3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sleep Wake Disorders
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anxiety Disorders
1
Interventions
pembrolizumab
97
Specimen Handling
79
Magnetic Resonance Spectroscopy
70
Carboplatin
60
Cisplatin
58
Biopsy
56
Nivolumab
51
Radiotherapy
47
Cyclophosphamide
45
Paclitaxel
43
durvalumab
36
Radiation
36
Gemcitabine
33
olaparib
30
Dexamethasone
30
Etoposide
29
Doxorubicin
28
atezolizumab
26
Taxes
25
Rituximab
25
Docetaxel
25
Ipilimumab
24
Bevacizumab
24
Vincristine
23
Pemetrexed
23
Lenalidomide
23
Cytarabine
22
X-Rays
21
Radiotherapy, Intensity-Modulated
21
Prednisone
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Exercise Test
×
90 days
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts